-
Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons.
J Neurosci. 2000 Oct 15;20(20):7602-13
PMID: 11027220
-
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
J Neurochem. 2001 Jan;76(2):435-41
PMID: 11208906
-
High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.
J Neurosci. 2000 Jun 1;20(11):4050-8
PMID: 10818140
-
Inflammation and Alzheimer's disease.
Neurobiol Aging. 2000 May-Jun;21(3):383-421
PMID: 10858586
-
Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system.
J Comp Neurol. 1998 Aug 31;398(3):373-92
PMID: 9714150
-
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.
J Neuropathol Exp Neurol. 2000 Oct;59(10):880-8
PMID: 11079778
-
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.
Ann Neurol. 1997 Jan;41(1):17-24
PMID: 9005861
-
Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway.
J Biol Chem. 1997 Feb 7;272(6):3296-301
PMID: 9013568
-
Unbiased stereological estimation of the number of neurons in the human hippocampus.
J Comp Neurol. 1990 Jun 1;296(1):1-22
PMID: 2358525
-
Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury.
J Neurosci. 1998 Jul 15;18(14):5124-35
PMID: 9651196
-
Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.
J Neurosci. 2000 Dec 1;20(23):8717-26
PMID: 11102478
-
Negative regulation of the SAPK/JNK signaling pathway by presenilin 1.
J Cell Biol. 2001 Apr 30;153(3):457-63
PMID: 11331298
-
Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.
J Neurosci. 2001 Oct 1;21(19):7551-60
PMID: 11567045
-
Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases.
FEBS Lett. 1997 Jun 2;409(1):57-62
PMID: 9199504
-
Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein.
Neuroscience. 1994 Jun;60(3):607-19
PMID: 7936190
-
beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation.
J Neurochem. 2001 Apr;77(1):157-64
PMID: 11279271
-
Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
J Neurochem. 2000 Apr;74(4):1587-95
PMID: 10737616
-
Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways.
J Biol Chem. 1998 Feb 27;273(9):4928-36
PMID: 9478937
-
Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.
Physiol Rev. 2001 Apr;81(2):807-69
PMID: 11274345
-
Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
J Neurosci. 2001 Jun 15;21(12):4125-33
PMID: 11404397
-
JNK activation is associated with intracellular beta-amyloid accumulation.
Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):221-33
PMID: 11146125
-
A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation.
J Biol Chem. 1997 Aug 1;272(31):19103-6
PMID: 9235897
-
Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome.
Ann Neurol. 1997 Feb;41(2):271-3
PMID: 9029078
-
Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia.
Neuroreport. 1998 Mar 30;9(5):871-4
PMID: 9579682
-
Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
J Biol Chem. 2001 Sep 7;276(36):34298-306
PMID: 11441005
-
Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.
Neuroreport. 1999 Aug 2;10(11):2411-5
PMID: 10439473
-
p38 kinase is activated in the Alzheimer's disease brain.
J Neurochem. 1999 May;72(5):2053-8
PMID: 10217284
-
CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis.
J Neurochem. 2001 May;77(3):849-63
PMID: 11331414
-
c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK.
J Neurosci. 2001 Sep 1;21(17):6597-607
PMID: 11517249
-
Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.
Nat Med. 1996 Aug;2(8):864-70
PMID: 8705854
-
Activation of MKK6, an upstream activator of p38, in Alzheimer's disease.
J Neurochem. 2001 Oct;79(2):311-8
PMID: 11677259
-
Brain Abeta amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau.
J Pathol. 2001 Aug;194(4):500-6
PMID: 11523060
-
beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes.
J Neurosci. 1998 Jun 15;18(12):4451-60
PMID: 9614222
-
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.
J Neuropathol Exp Neurol. 2001 Dec;60(12):1190-7
PMID: 11764091
-
Structure, microtubule interactions, and phosphorylation of tau protein.
Ann N Y Acad Sci. 1996 Jan 17;777:96-106
PMID: 8624133
-
Mutations of the presenilin I gene in families with early-onset Alzheimer's disease.
Hum Mol Genet. 1995 Dec;4(12):2373-7
PMID: 8634712
-
Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention.
Ann N Y Acad Sci. 1996 Jan 17;777:132-8
PMID: 8624075
-
Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model.
Ann N Y Acad Sci. 2000;920:134-9
PMID: 11193142
-
Familial Alzheimer's chromosome 14 mutations.
Nat Med. 1995 Sep;1(9):848
PMID: 7585193
-
Mammalian MAP kinase signalling cascades.
Nature. 2001 Mar 1;410(6824):37-40
PMID: 11242034
-
Peripheral axotomy induces long-term c-Jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia In vivo.
J Neurosci. 1998 Feb 15;18(4):1318-28
PMID: 9454841
-
Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3228-33
PMID: 10077666
-
Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
J Neuropathol Exp Neurol. 2001 Apr;60(4):357-68
PMID: 11305871
-
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.
Science. 1996 Oct 4;274(5284):99-102
PMID: 8810256
-
FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.
Neurobiol Aging. 2002 May-Jun;23(3):335-48
PMID: 11959395
-
Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Brain Pathol. 2001 Apr;11(2):144-58
PMID: 11303790
-
Neuron loss in APP transgenic mice.
Nature. 1998 Oct 22;395(6704):755-6
PMID: 9796810
-
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.
Nature. 1998 Jun 18;393(6686):702-5
PMID: 9641683
-
Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.
J Neurosci. 1999 Apr 1;19(7):2706-16
PMID: 10087083
-
Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain.
J Biol Chem. 1999 Mar 5;274(10):6483-92
PMID: 10037741
-
Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease.
Lancet. 1994 Sep 17;344(8925):769-72
PMID: 7916070
-
Structural correlates of cognition in dementia: quantification and assessment of synapse change.
Neurodegeneration. 1996 Dec;5(4):417-21
PMID: 9117556
-
CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults.
J Neurochem. 1999 Nov;73(5):1901-12
PMID: 10537048
-
Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology.
Exp Neurol. 1994 Feb;125(2):286-95
PMID: 8313943
-
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation.
Neuron. 1998 Oct;21(4):869-83
PMID: 9808472
-
DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay.
J Neurosci. 1996 Mar 1;16(5):1710-9
PMID: 8774439
-
Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3).
J Neurochem. 2001 Jan;76(1):316-20
PMID: 11146006
-
Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.
J Neurosci. 2001 Jul 15;21(14):4987-95
PMID: 11438574
-
CEP-1347/KT7515, a JNK pathway inhibitor, supports the in vitro survival of chick embryonic neurons.
Neuroreport. 1998 May 11;9(7):1435-9
PMID: 9631443